Posted by Michael Wonder on 17 Apr 2018
Listing of life-saving cancer medicine to save patients more than $200,000
16 April 2018 - The Turnbull Government will drastically reduce the cost of a life-saving new medicine, which uses a patient’s own immune system to track down and destroy cancer cells.
From 1 May, classical Hodgkin’s lymphoma patients will no longer pay over $200,000 per course of treatment, now only paying a maximum of $39.50 per script, with concessional patients–including pensioners–paying just $6.40.
We have also made Yervoy available for the treatment of unresectable Stage II or Stage IV malignant melanoma.
Also on May 1, we will make other medicines available to treat a range of conditions, including non-small cell lung cancer, epilepsy and ulcerative colitis.
